浆细胞疾病中的炎症与感染:病原体如何塑造患者命运
本文综述感染和慢性炎症在浆细胞疾病(PCD)中的作用,指出感染是多数PCD的常见并发症和重要致病致死原因,免疫治疗影响感染流行病学;同时探讨病原体通过慢性炎症和免疫应答影响疾病生物学,呼吁大规模研究解析微生物组和直接病原体在骨髓瘤自然史中的作用。
要点
- 感染是多数浆细胞疾病的常见并发症,也是重要致病和致死原因。
- 免疫治疗应用增加,需认识其对感染流行病学的影响并识别预防措施。
- 病原体可能通过病原暴露、慢性炎症和免疫应答的复杂相互作用影响疾病生物学。
核心结论
- 感染和病原体作为实体,被认为通过涉及病原暴露、慢性炎症和免疫应答的复杂相互作用,从起始到治疗反应和进展影响疾病生物学。
研究设计与样本
- 综述,概述导致浆细胞疾病高感染风险的多重因素,并探讨病原体在浆细胞疾病中的直接和间接作用。
主要发现
- 感染是多数浆细胞疾病的常见并发症,也是该人群显著致病和致死原因。
- 导致高感染风险的因素包括基础疾病状态、患者年龄和合并症以及骨髓瘤导向治疗。
- 免疫治疗在多发骨髓瘤中日益增多,需认识其对感染流行病学的影响并识别预防措施。
局限性
- 需要大规模研究来解析微生物组和直接病原体在骨髓瘤及其前驱疾病状态自然史中的确切意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The role of infection and chronic inflammation in plasma cell disorders (PCD) has been well-described. Despite not being a diagnostic criterion, infection is a common complication of most PCD and represents a significant cause of morbidity and mortality in this population. As immune-based therapeutic agents are being increasingly used in multiple myeloma, it is important to recognize their impact on the epidemiology of infections and to identify preventive measures to improve outcomes. This review outlines the multiple factors attributed to the high infectious risk in PCD (e.g. the underlying disease status, patient age and comorbidities, and myeloma-directed treatment), with the aim of highlighting future prophylactic and preventive strategies that could be implemented in the clinic. Beyond this, infection and pathogens as an entity are believed to also influence disease biology from initiation to response to treatment and progression through a complex interplay involving pathogen exposure, chronic inflammation, and immune response. This review will outline both the direct and indirect role played by oncogenic pathogens in PCD, highlight the requirement for large-scale studies to decipher the precise implication of the microbiome and direct pathogens in the natural history of myeloma and its precursor disease states, and understand how, in turn, pathogens shape plasma cell biology.
引用
- Caro J, Braunstein M, Williams L, et al. Inflammation and infection in plasma cell disorders: how pathogens shape the fate of patients. Leukemia. 2022. PMID: 35110727. doi:10.1038/s41375-021-01506-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。